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stones
Abstract
H(+)-ATPases mediate urinary acidification along the collecting duct, and mutations in their B1 and a4
subunits result in distal renal tubular acidosis. The pathomechanisms by which these mutations affect
pump activity are only poorly understood. Common polymorphisms may impair pump activity and may
link the pump to a higher risk for alkaline urine and the development of kidney stones.
 
 
 
 
 
 
 
 
 
 
When proton pumps go sour – urinary acidification  
 
and kidney stones 
 
 
 
 
 
Carsten A Wagner 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Carsten A. Wagner 
Institute of Physiology and Zurich Center for Integrative Human Physiology 
University of Zurich 
Winterthurerstrasse 190 
CH-8057 Zurich 
Switzerland 
Phone: +41-44-63 50659 
Fax: +41-44-63 56814 
E-mail: Wagnerca@access.uzh.ch 
 
 
 2
Abstract 
H+-ATPases mediate urinary acidification along the collecting duct and mutations in 
its B1 and a4 subunits result in distal renal tubular acidosis. The pathomechanism by 
which these mutations affect pump activity are only poorly understood. Common 
polymorphisms may impair pump activity and may link the pump to a higher risk for 
alkaline urine and developing kidney stones. 
 
 
 
Urinary acidification serves the major purpose of excreting acid stemming from daily 
metabolism – about 70 mmoles per day. This process is mainly mediated by the 
action of electrogenic V-type (vacuolar-type) H+-ATPases that convey the hydrolysis 
of ATP to pumping protons across the plasma membrane [1, 2]. In the kidney such 
H+-ATPases are found in many epithelial cells lining the nephron and collecting duct 
system. In the proximal tubule, H+-ATPases are involved in the first step of 
bicarbonate reabsorption from the urine as well as in acidifying endocytic vesicles. In 
the collecting duct system (i.e. connecting tubule, cortical and outer medullary 
collecting duct and initial inner medullary collecting duct), H+-ATPases are mainly 
found in intercalated cells where these pumps can be localized in the luminal 
membrane of acid-secretory type A intercalated cells and in the basolateral and/or 
luminal side of type B and non-A/non-B intercalated cells, respectively.  
H+-ATPases are multi-subunit protein complexes that consist in humans of at least 14 
subunits with often multiple isoforms [2]. The expression of these isoforms may be 
tissue or cell specific, in some cases also multiple isoforms are expressed in the 
same cell but with distinct subcellular localization [3, 4]. It is assumed that specific 
isoforms are involved in targeting and regulation of different subsets of pumps as 
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indicated by experiments with yeast vacuolar H+-ATPases [1, 2]. The subunits of the 
proton pump are organized in two domains, a membrane bound V0 domain and a 
cytosolic V1 domain. The V0 domain forms the proton translocation pore whereas the 
V1 domain binds and hydrolyzes ATP which induces a conformational change in the 
V0 domain conveyed through a connecting stalk structure. Proton pump activity can 
be regulated by several mechanisms: assembly and disassembly of the V1 and V0 
domain, changes in the ATP to proton pumping coupling efficiency, and trafficking 
into and retrieval from the membrane [1, 2]. Again, some of these regulatory 
mechanisms seem to be different between subunit isoforms.   
The biological importance of H+-ATPases is underlined by the fact that genetic 
knock-out of the ubiquitous proteolipid subunit ATP6V0C (c-subunit) leads to early 
embryonic death due to impaired nidation [5]. In humans, at least three different 
genes have been found to be mutated in rare inherited diseases. Mutations of the 
ATP6V0A3 (a3 subunit) cause infantile osteopetrosis [6, 7], a renal phenotype of 
these patients and corresponding KO mice has not been reported yet despite the 
expression of this gene in kidney. Mutations in the ATP6V1B1 (B1 subunit) or the 
ATP6V0A4 (a4 subunit) are responsible for syndromes of distal renal tubular acidosis 
which are often associated with progressive sensorineural deafness due to the 
extrarenal expression of these subunits in the inner ear [8, 9]. The B1 subunit, 
(wrongly) often referred to also as the kidney-specific subunit, is mostly expressed in 
the kidney (all types of intercalated cells), but also in epididymis, lung, and inner ear. 
Similarly, the a4 isoform is highly expressed in kidney (there in most epithelial cells 
along the nephron), the epididymis, and inner ear [10]. Patients carrying homozygous 
mutations in the ATP6V1B1 and ATP6V0A4 genes often present early after birth with 
hypokalemic metabolic acidosis, an inappropriately alkaline urine, a high 
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susceptibility to dehydration, hypercalciuria, and with progressive hearing loss. Less 
severe cases may be identified later in life due to nephrocalcinosis or kidney stones.  
Alkaline urine pH and the occurrence of calcium kidney stones are closely 
linked in the general population as indicated by many studies in patients and animal 
models [11, 12]. At least two mechanisms may favour the development of calcium 
stones in this setting: the lower solubility of calcium in alkaline urine and an incipient 
or overt metabolic acidosis as part of a renal tubular acidosis (RTA) syndrome. 
Forms of complete and incomplete RTA have been frequently detected in patients 
with a high (re)occurrence rate of calcium kidney stones. Thus, inappropriate urinary 
acidification along the collecting duct mediated by proton pumps could contribute to 
the development of calcium kidney stones, not only in patients with homozygous 
mutations but also in a more general population. However, only little is known about 
the functional consequences of proton pump subunit mutations detected in dRTA 
patients. Moreover, polymorphisms for some of these subunit isoforms have been 
described but their functional relevance not been investigated. The functional 
investigation of particular subunit isoforms is hampered by the fact that mammalian 
cells often express more than one isoform of a given pump subunit and that different 
isoforms may substitute for at least some functions of the missing or defective 
isoform. We and others found that in a mouse model deficient for the B1 subunit 
(Atp6v1b1 KO) residual proton pump activity and urinary acidification is preserved in 
the collecting duct [13-15]. This finding was surprising at first glance but we detected 
that the B2 isoform was partially substituting for the loss of the B1 isoform. 
Interestingly, the B2 isoform cannot substitute for all functions as indicated by the fact 
that induction of metabolic acidosis in these animals results in severe dRTA, impaired 
urinary acidification and no stimulation of H+-ATPase activity could be observed in 
intercalated cells from KO animals. Similarly, angiotensin II stimulates H+-ATPase 
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activity in OMCD intercalated cells from normal animals but not from mice lacking the 
B1 isoform. Thus, the B2 isoform can support some basal H+-ATPase activity in the 
plasma membrane but the B1 isoform is required for the stimulation of pump activity 
as it occurs in settings of acid-loading.    
In this issue of Kidney International, Fuster and colleagues have overcome the 
problem of studying mutant B1 subunits in the background of cells expressing the B2 
isoform by expressing wildtype and mutant human B1 isoforms in yeast cells that 
were engineered to lack all corresponding B isoforms [16]. This elegant yeast 
complementation assay allowed them to examine the impact of B1 mutations 
detected in dRTA patients on assembly and function of the whole proton pump. Most 
mutations investigated disturbed assembly of the proton pump domains. Some 
mutants showed apparently normal pump assembly but did not rescue the reduced 
growth of complemented yeast strains at alkaline pH indicating that these mutants 
impaired pump activity despite normal assembly. Coexpression of wildtype and 
mutant B1 isoforms did not impair proton pump assembly or function in agreement 
with the autosomal recessive inheritance of this disease. Most interestingly, two 
alleles were investigated, the Thr30Ile and Glu161Lys alleles, that had been 
previously considered a common polymorphism. The Thr30Ile did not show any 
defects and can be indeed viewed as polymorphism whereas the Glu161Lys showed 
strongly impaired proton pump activity despite normal assembly. Some of these 
results are in contrast to previous investigations testing the impact of B1 and a4 
isoform mutations [17, 18]. These studies had also found evidence for impaired pump 
assembly and function but suggested that mutant B1 protein could exert a dominant 
negative effect on the assembly and trafficking of normal pumps when coexpressed. 
Some of the discrepancies may be due to the fact that mutant isoforms were highly 
overexpressed and that a rat collecting duct cell line was used that expressed both 
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normal B1 and B2 isoforms [18]. It will not be easy to resolve such discrepancies as 
long as we do not have good cell models at hand that resemble human intercalated 
cells. Furthermore, all models rely on the (over)expression of wildtype or mutant 
proteins which may alter stoichiometries between isoforms and alleles. Unfortunately, 
very little is known about expression of H+-ATPase subunits in human kidney, as 
most studies were performed in rodent models, and no data are available on the 
situation in the kidney from patients with ATP6V1B1 mutations. However, the story 
resembles data obtained on the expression of wildtype and mutant AE1 proteins. 
Mutations in chloride/anion exchanger AE1 (SLC4A1) cause autosomal dominant 
dRTA [19, 20] as this transporter is expressed on the basolateral side of intercalated 
cells of the kidney. Expression of mutants in renal cell lines indicated that in some 
instances loss of polarized expression with trafficking of otherwise functional 
transporters to the luminal side with possible bicarbonate wasting into urine would 
underlie the disease [21, 22]. Among these mutants is the S613F mutant which is 
found on the apical membrane in overexpressing cell lines. However, investigating a 
rare biopsy from a dRTA patient with this mutation did not show any detectable 
luminal expression of the mutant but rather intracellular or even absent staining [23]. 
Thus, data from overexpression systems should be taken with great caution. What 
are the alternatives ? The generation of humanized mouse models that do not lack 
the gene of interest but express the mutant gene recapitulating human mutations 
may be an additional useful tool, even though not suited for high throughput 
screening of mutations. Tissues or cells from patients would be another attractive 
way, however, the attempts to raise good renal cell lines are numerous, but only little 
progress has been made. Yeast cell lines as used here by Fuster et al. is another 
alternative as in the case of proton pumps much is known about the biology of yeast 
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V-ATPases, genetic models lacking subunits of the yeast pump, and easy 
complementation assays are at hand.  
The work of Fuster and colleagues goes beyond investigating the direct impact 
of B1 mutations on pump assembly and function. They suggest that alleles viewed as 
polymorphisms of proton pump subunits may actually be genuine mutations impairing 
urinary acidification. In view of the link between reduced urinary acidification and 
calcium stone formation, it may be well worth to take a closer look at such 
polymorphisms found in these patients. Even though full blown dRTA is caused only 
in the presence of two mutated alleles, it may be enough to carry one dysfunctional 
allele to reduce urinary acidification to an extent sufficient to increase the risk of 
kidney stone formation. 
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Figure legend 
 
Acid-secretory type A intercalated cells are localized along the collecting duct system 
from late distal convoluted tuble (DCT2) to the initial inner medullary collecting duct. 
Cytosolic carbonic anhydrase II (CA II) catalyzes the formation of bicarbonate and 
protons. Bicarbonate is released across the basolateral membrane into the 
pericapillary interstitium via chloride/bicarbonate exchanger(s), whereas protons are 
secreted into urine mainly by the vacuolar type H+-ATPase (V-H+-ATPase) and to a 
lesser extent by H+/K+-ATPases. H+-ATPases are composed of two main sectors, the 
cytosolic V1 domain (depicted in orange) and the membrane bound V0 domain 
(depicted in blue). ATP binds to the V1 domain and its hydrolysis provides the energy 
to pump protons across the cell membrane embedded V0 domain. Both domains are 
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assembled from several subunits with often many isoforms. Two isoforms of the B 
subunit exist, B1 (ATP6V1B1) and B2, the ‘a’ subunit exists in four isoforms 
(ATP6V0A1-4). Mutations in the B1 and a4 subunit isoforms, respectively, have been 
detected in patients with distal renal tubular acidosis due to the impaired proton 
secretion by proton pumps.  
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